Processa Pharmaceuticals, Inc. Capitalized Computer Software, Impairments
Processa Pharmaceuticals, Inc. (PCSA) reported Capitalized Computer Software, Impairments of $15.33 thousand for the 12-month period ending 2017-12-31, per its 10-K/A filed 2019-04-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareImpairments1 · last filed 2019-04-08
- Processa Pharmaceuticals, Inc. capitalized computer software, impairments for fiscal 2017 was $15.33K.
| Period end | Capitalized Computer Software, Impairments 12 month |
|---|---|
| 2017-12-31 | $15.33K 10-K/A · filed 2019-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |